Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06990425 · ClinicalTrials.gov registry record · NA
CLOSM Trial: Groin Closure Using Layered Option for Suture Material
A NA study of Vascular Diseases, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 259
- Enrollment target
- 1
- Study location
NCT06990425: Recruiting NA study of Vascular Diseases, sponsored by The Cleveland Clinic.
NCT06990425 is a NA study of Vascular Diseases that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 259 participants, below the 555-participant average among 40 other Vascular Diseases trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06990425, a NA study of Vascular Diseases, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 259 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized controlled trial comparing groin closure after vascular intervention with Vicryl suture versus PDS (polydioxanone) suture. This will be a single center trail performed at CCF main campus. Patients will be enrolled in a prospective fashion and will be randomized 1:1 to either PDS or Vicryl closure. Patients undergoing bilateral groin exposure will be randomized to receive both closure types to either groin.
Primary Outcome
Number of occurrence of the access site complication
Conditions Studied
Interventions
- PROCEDURE Groin closure with PDS suture
- PROCEDURE Groin closure suture material
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2025-03-27 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT06990425 shows while recruiting
NCT06990425 is an interventional study that assigns participants to a tested intervention. The registered 259 participants enrollment target is mid-sized for trials with a published cap, below the 555-participant average among 40 other Vascular Diseases trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Vascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Groin closure with PDS suture is the first listed.
NCT06990425 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06990425 about?
NCT06990425 is a clinical study titled "CLOSM Trial: Groin Closure Using Layered Option for Suture Material". This is a randomized controlled trial comparing groin closure after vascular intervention with Vicryl suture versus PDS (polydioxanone) suture. This will be a single center trail performed at CCF main campus. Patients will be enrolled in a prospective fashion and will be randomized 1:1 to either PDS...
What is the current status of trial NCT06990425?
This trial is currently recruiting. It is a NA study. The enrollment target is 259 participants. The study started on 2025-03-27. Estimated completion is 2027-12-31.
What conditions does trial NCT06990425 study?
This clinical trial studies the following conditions: Vascular Diseases.
What interventions are being tested in trial NCT06990425?
The interventions under investigation include: Groin closure with PDS suture (PROCEDURE), Groin closure suture material (PROCEDURE).
Who is sponsoring clinical trial NCT06990425?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06990425 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06990425's enrollment target sits among peer trials
259 17th of 40 higher than 24 of 40 other Vascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
RECRUITING · NA
-
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
RECRUITING · NA
-
SPYRAL GEMINI Pilot Study
RECRUITING · NA
-
Passive Limb Movement Study
RECRUITING · NA
-
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02361320 · 259 participants · NA
Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- NCT06797258 · 259 participants · NA
FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction
- NCT07399977 · 259 participants · NA
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI